Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for EMNSF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for EMNSF and 80,000+ other tickers.
See exactly how EMNSF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for EMNSF and 80,000+ other tickers.
Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Coatings and Personal Care. The Coatings segment offers production of rheological modifiers and additives for decorative and industrial coatings; and performance chemicals for the energy sector. This segment provides products for applications in architectural and industrial coatings, adhesives, and sealants and construction additives. The Personal Care segment offers rheological modifiers and compounded products, including active…
Elementis plc (ELMTY) Q4 2025 Earnings Call Transcript
Elementis delivered robust 2024 results, with improved gross profit and cash flow despite a reported net loss due to a talc business impairment. Q1 2025 update shows margin improvement and cost savings progress, reinforcing management's 2026 targets for higher margins and return on capital. Strategic review of the talc business continues; a sale could boost margins and reduce debt, but risks selling a valuable asset below its purchase price.
Elementis is a specialty chemicals company focusing on personal healthcare and coatings, with a market capitalization of approximately $1.05B. The company's free cash flow profile is strong, with an underlying free cash flow per share of approximately $0.056 or 4.4 pence in the first semester of last year. Elementis expects to report an operating profit of $102-104M in 2023 and aims to achieve a full-year revenue of $800M and an operating margin of 19% in the future.
Elementis is a specialty chemicals manufacturer, supplying different additives to the personal care, premium coatings, automotive and paper industries among others. The company owns valuable assets such as the only high-quality rheology grade hectorite mine in the world.